North America Self Injection Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
North America self-injection market is expected to reach USD 23,540.98 million by 2024 from USD 10,228.89 million in 2016, at a CAGR of 11.0% in the forecast period 2017 to 2024.
Based on geography, the North America self-injection market is segmented into 5 geographical regions, such as,
Becton, Dickinson and Company is the major player in the United States for self-injection market as it has done lot of merger and acquisitions, partnerships and expansion. Some of the prominent players in the self-injection market include
The global self injection market is segmented into 4 types, namely needle free injectors (NFI), auto injectors, pen injectors, and wearable injectors. In 2017, needle free injector market segment is expected to account for the largest share of 44.8%.
On the basis of applications, the global self-injection market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others.
On the basis of usage pattern the global self-injection market is segmented into curative care, immunization.
Based on mode of administration the market is segmented into skin, circulatory, organs and central nervous system.
On the basis of end user the global self-injection market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies. In 2017 hospitals and clinics segment dominated the market and the trend is expected to remain the same till 2024.
Based on distribution channel, global self injection market is segmented into Pharmacy stores, direct tender, hospital pharmacy, and online pharmacy.
Based on geography, the North America self-injection market is segmented into 5 geographical regions, such as,
- U.S.
- Mexico
- Canada
Becton, Dickinson and Company is the major player in the United States for self-injection market as it has done lot of merger and acquisitions, partnerships and expansion. Some of the prominent players in the self-injection market include
- Novo Nordisk
- Sanofi
- Pfizer
- Mylan N.V.
- Gerresheimer AG
- West Pharmaceutical Services, Inc.
- Ypsomed, Antares Pharma
- UNILIFE CORPORATION
The global self injection market is segmented into 4 types, namely needle free injectors (NFI), auto injectors, pen injectors, and wearable injectors. In 2017, needle free injector market segment is expected to account for the largest share of 44.8%.
On the basis of applications, the global self-injection market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others.
On the basis of usage pattern the global self-injection market is segmented into curative care, immunization.
Based on mode of administration the market is segmented into skin, circulatory, organs and central nervous system.
On the basis of end user the global self-injection market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies. In 2017 hospitals and clinics segment dominated the market and the trend is expected to remain the same till 2024.
Based on distribution channel, global self injection market is segmented into Pharmacy stores, direct tender, hospital pharmacy, and online pharmacy.
1. INTRODUCTION
1.1. OVERVIEW OF NORTH AMERICA SELF-INJECTION MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF CHRONIC DISEASES
3.1.2. RISING DEMAND OF SELF-INJECTION DEVICES
3.1.3. GROWTH OF BIOLOGICS MARKET
3.1.4. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET
3.2. RESTRAINTS
3.2.1. HIGH COST OF DEVELOPMENT
3.2.2. STRICT REGULATORY FRAMEWORK
3.3. OPPORTUNITY
3.3.1. INCREASING DEMAND FOR GENERIC AND BIOSIMILAR DRUGS
3.3.1.1. GENERICS
3.3.1.2. BIOSIMILARS
3.3.2. INCREASING DEMAND FOR CONTRACEPTIVE INJECTABLES
3.3.3. INCREASING DEMAND FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. ALTERNATIVE ROUTE OF DRUG ADMINISTRATION
3.4.2. PRODUCT RECALL
3.4.3. STABILITY OF PRODUCTS
3.4.4. STERILITY OF INJECTIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. NORTH AMERICA SELF-INJECTION MARKET, REGULATORY
6.1. OVERVIEW
6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
7. NORTH AMERICA SELF-INJECTION MARKET, REIMBUSEMENT
7.1. OVERVIEW
7.2. REIMBURSEMENT SCENARIO
8. NORTH AMERICA SELF-INJECTION MARKET, BY TYPE
8.1. OVERVIEW
8.2. NORTH AMERICA SELF-INJECTION MARKET, BY PRODUCT TYPE
8.2.1. NEEDLE FREE INJECTORS (NFI)
8.2.1.1. NEEDLE FREE INJECTORS, BY PRODUCT
8.2.1.2. NEEDLE FREE INJECTORS, BY TECHNOLOGY
LASER BASED NEEDLE FREE INJECTORS:
VIBRATION BASED NEEDLE FREE INJECTORS:
8.2.1.3. NEEDLE FREE INJECTORS, BY USABILITY
REUSABLE NEEDLE-FREE INJECTORS
DISPOSABLE NEEDLE-FREE INJECTORS
8.2.2. AUTO INJECTORS
8.2.2.1. AUTO INJECTORS, BY PRODUCT
FILLABLE AUTO INJECTORS
PRE-FILLED AUTO INJECTORS
8.2.2.2. AUTO INJECTORS, BY TECHNOLOGY
AUTOMATED AUTO INJECTORS
MANUAL AUTO INJECTORS
8.2.2.3. AUTO INJECTORS, BY DESIGN
STANDARDIZED AUTO INJECTORS
CUSTOMIZEDAUTO INJECTORS
8.2.2.4. AUTO INJECTORS, BY USABILITY
REUSABLE AUTO INJECTORS
DISPOSABLE AUTO INJECTORS
8.2.3. PEN INJECTORS
8.2.3.1. PEN INJECTORS, BY PRODUCT
SINGLE CHAMBERED PEN INJECTORS
DUAL CHAMBERED PEN INJECTORS
8.2.3.2. PEN INJECTORS, BY DESIGN
STANDARD PEN INJECTORS
CUSTOMIZED PEN INJECTORS
8.2.3.3. PEN INJECTORS, BY USABILITY
REUSABLE PEN INJECTORS
DISPOSABLE PEN INJECTORS
8.2.4. WEARABLE INJECTORS
9. NORTH AMERICA SELF-INJECTION MARKET, BY APPLICATION
9.1. OVERVIEW
9.2. NORTH AMERICA SELF-INJECTION MARKET, BY APPLICATION
9.3. HORMONAL DISORDERS
9.3.1. SELF-INJECTIONS FOR DIABETES
9.3.2. SELF-INJECTIONSFOR ANEMIA
9.3.3. REPRODUCTIVE HEALTH DISEASE
9.3.4. OSTEOPOROSIS
9.3.5. GROWTH HORMONE DISORDERS (GHD)
9.4. ONCOLOGY
9.5. AUTOIMMUNE DISEASES
9.5.1. RHEUMATOID ARTHRITIS
9.5.2. MULTIPLE SCLEROSIS
9.5.3. CROHN’S DISEASES
9.5.4. PSORIASIS
9.5.5. OTHER AUTOIMMUNE DISEASES
9.6. ORPHAN DISEASE
9.7. OTHER APPLICATIONS
9.7.1. PAIN MANAGEMENT
9.7.2. ALLERGY TREATMENT
9.7.3. AESTHETIC TREATMENTS
9.7.4. HEPATITIS C
9.7.5. HEMOPHILIA
10. NORTH AMERICA SELF-INJECTION MARKET, BY USAGE PATTERN
10.1. OVERVIEW
10.2. CURATIVE CARE
10.3. IMMUNIZATIONS
10.4. OTHER USAGE PATTERN
11. NORTH AMERICA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION
11.1. OVERVIEW
11.2. SKIN
11.3. CIRCULATORY/ MUSKOSKELETAL
11.4. ORGANS
11.5. CENTRAL NERVOUS SYSTEM
12. NORTH AMERICA SELF-INJECTION MARKET, BY END USER
12.1. OVERVIEW
12.2. HOSPITALS AND CLINICS
12.3. HOME HEALTHCARE SETTINGS
12.4. RESEARCH LABORATORIES
12.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
12.6. OTHER END USER
13. NORTH AMERICA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL
13.1. OVERVIEW
13.1.1. HOSPITAL PHARMACY
13.1.2. PHARMACY STORES
13.1.3. DIRECT TENDER
13.1.4. ONLINE PHARMACY
14. NORTH AMERICA SELF-INJECTION MARKET, BY GEOGRAPHY
14.1. OVERVIEW
14.2. NORTH AMERICA
14.2.1. U.S.
14.2.2. CANADA
14.2.3. MEXICO
15. NORTH AMERICA SELF INJECTION MARKET, COMPANY LANDSCAPE
15.1. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3. COMPANY SHARE ANALYSIS: EUROPE
15.4. COMPANY SHARE ANALYSIS: APAC
16. COMPANY PROFILES
16.1. ELCAM MEDICALCOMPANY OVERVIEW
16.1.1. ELCAM MEDICAL: COMPANY SNAPSHOT
16.1.2. PRODUCT PORTFOLIO
16.1.3. RECENT DEVELOPMENTS
16.2. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
16.2.1. COMPANY OVERVIEW
16.2.2. BESPAK: REVENUE ANALYSIS
16.2.3. PRODUCT PORTFOLIO
16.2.4. RECENT DEVELOPMENTS
16.3. SANOFI
16.3.1. COMPANY OVERVIEW
16.3.2. SANOFI: REVENUE ANALYSI
16.3.3. PRODUCT PORTFOLIO
16.3.4. RECENT DEVELOPMENTS
16.4. SANDOZ INTERNATIONAL GMBH
16.4.1. COMPANY OVERVIEW
16.5. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS
16.5.1. PRODUCT PORTFOLIO
16.5.2. RECENT DEVELOPMENTS
16.6. UNILIFE CORPORATION
16.6.1. COMPANY OVERVIEW
16.6.2. UNILIFE CORPORATION: REVENUEANALYSIS
16.6.3. PRODUCT PORTFOLIO
16.6.4. RECENT DEVELOPMENTS
16.7. WEST PHARMACEUTICAL SERVICES, INC
16.7.1. COMPANY OVERVIEW
16.7.2. WEST PHARMACEUTICAL SERVICES, INC: REVENUE ANALYSIS
16.7.3. PRODUCT PORTFOLIO
16.7.4. RECENT DEVELOPMENTS
16.8. PFIZER INC.
16.8.1. COMPANY OVERVIEW
16.8.2. PFIZER INC: REVENUE ANALYSIS
16.8.3. PRODUCT PORTFOLIO
16.8.4. RECENT DEVELOPMENTS
16.9. IMPAX LABORATORIES, INC.
16.9.1. COMPANY OVERVIEW
16.9.2. IMPAX LABORATORIES, INC: REVENUE ANALYSIS
16.9.3. PRODUCT PORTFOLIO
16.9.4. RECENT DEVELOPMENTS
16.10. PENJET CORPORATION
16.10.1. COMPANY OVERVIEW
16.10.2. PENJET CORPORATION: COMPANY SNAPSHOT
16.10.3. PRODUCT PORTFOLIO
16.10.4. RECENT DEVELOPMENTS
16.11. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS
16.11.1. COMPANY OVERVIEW
16.11.2. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS: COMPANY SNAPSHOT
16.11.3. PRODUCT PORTFOLIO
16.11.4. RECENT DEVELOPMENTS
16.12. WILHELM HASELMEIER GMBH & CO. KG
16.12.1. COMPANY OVERVIEW
16.12.2. HASELMEIER: COMPANY SNAPSHOT
16.12.3. PRODUCT PORTFOLIO
16.12.4. RECENT DEVELOPMENTS
16.13. ANTARES PHARMA
16.13.1. COMPANY OVERVIEW
16.13.2. ANTARES PHARMA: REVENUE ANALYSIS
16.13.3. PRODUCT PORTFOLIO
16.13.4. RECENT DEVELOPMENTS
16.14. BECTON, DICKINSON AND COMPANY
16.14.1. COMPANY OVERVIEW
16.14.2. BECTON, DICKINSON AND COMPANY: REVENUE ANALYSIS
16.14.3. PRODUCT PORTFOLIO
16.14.4. RECENT DEVELOPMENTS
16.15. GERRESHEIMER AG
16.15.1. COMPANY OVERVIEW
16.15.2. GERRESHEIMER AG: REVENUE ANALYSIS
16.15.3. PRODUCT PORTFOLIO
16.15.4. RECENT DEVELOPMENTS
16.16. MYLAN N.V
16.16.1. COMPANY OVERVIEW
16.16.2. MYLAN N.V.: REVENUE ANALYSIS
16.16.3. PRODUCT PORTFOLIO
16.16.4. RECENT DEVELOPMENTS
16.17. NOVO NORDISK
16.17.1. COMPANY OVERVIEW
16.17.2. NOVO NORDISK: REVENUE ANALYSIS
16.17.3. PRODUCT PORTFOLIO
16.17.4. RECENT DEVELOPMENTS
16.18. OWEN MUMFORD LTD
16.18.1. COMPANY OVERVIEW
16.18.2. OWEN MUMFORD LTD: COMPANY SNAPSHOT
16.18.3. PRODUCT PORTFOLIO
16.18.4. RECENT DEVELOPMENTS
16.19. PHARMAJET
16.19.1. COMPANY OVERVIEW
16.19.2. PHARMAJET: COMPANY SNAPSHOT
16.19.3. PRODUCT PORTFOLIO
16.19.4. RECENT DEVELOPMENTS
16.20. SHL GROUP
16.20.1. COMPANY OVERVIEW
16.20.2. SHL GROUP: COMPANY SNAPSHOT
16.20.3. PRODUCT PORTFOLIO
16.20.4. RECENT DEVELOPMENTS
16.21. YPSOMED
16.21.1. COMPANY OVERVIEW
16.21.2. YPSOMED: REVENUE ANALYSIS
16.21.3. PRODUCT PORTFOLIO
16.21.4. RECENT DEVELOPMENTS
17. RELATED REPORTS
1.1. OVERVIEW OF NORTH AMERICA SELF-INJECTION MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF CHRONIC DISEASES
3.1.2. RISING DEMAND OF SELF-INJECTION DEVICES
3.1.3. GROWTH OF BIOLOGICS MARKET
3.1.4. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET
3.2. RESTRAINTS
3.2.1. HIGH COST OF DEVELOPMENT
3.2.2. STRICT REGULATORY FRAMEWORK
3.3. OPPORTUNITY
3.3.1. INCREASING DEMAND FOR GENERIC AND BIOSIMILAR DRUGS
3.3.1.1. GENERICS
3.3.1.2. BIOSIMILARS
3.3.2. INCREASING DEMAND FOR CONTRACEPTIVE INJECTABLES
3.3.3. INCREASING DEMAND FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. ALTERNATIVE ROUTE OF DRUG ADMINISTRATION
3.4.2. PRODUCT RECALL
3.4.3. STABILITY OF PRODUCTS
3.4.4. STERILITY OF INJECTIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. NORTH AMERICA SELF-INJECTION MARKET, REGULATORY
6.1. OVERVIEW
6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
7. NORTH AMERICA SELF-INJECTION MARKET, REIMBUSEMENT
7.1. OVERVIEW
7.2. REIMBURSEMENT SCENARIO
8. NORTH AMERICA SELF-INJECTION MARKET, BY TYPE
8.1. OVERVIEW
8.2. NORTH AMERICA SELF-INJECTION MARKET, BY PRODUCT TYPE
8.2.1. NEEDLE FREE INJECTORS (NFI)
8.2.1.1. NEEDLE FREE INJECTORS, BY PRODUCT
8.2.1.2. NEEDLE FREE INJECTORS, BY TECHNOLOGY
LASER BASED NEEDLE FREE INJECTORS:
VIBRATION BASED NEEDLE FREE INJECTORS:
8.2.1.3. NEEDLE FREE INJECTORS, BY USABILITY
REUSABLE NEEDLE-FREE INJECTORS
DISPOSABLE NEEDLE-FREE INJECTORS
8.2.2. AUTO INJECTORS
8.2.2.1. AUTO INJECTORS, BY PRODUCT
FILLABLE AUTO INJECTORS
PRE-FILLED AUTO INJECTORS
8.2.2.2. AUTO INJECTORS, BY TECHNOLOGY
AUTOMATED AUTO INJECTORS
MANUAL AUTO INJECTORS
8.2.2.3. AUTO INJECTORS, BY DESIGN
STANDARDIZED AUTO INJECTORS
CUSTOMIZEDAUTO INJECTORS
8.2.2.4. AUTO INJECTORS, BY USABILITY
REUSABLE AUTO INJECTORS
DISPOSABLE AUTO INJECTORS
8.2.3. PEN INJECTORS
8.2.3.1. PEN INJECTORS, BY PRODUCT
SINGLE CHAMBERED PEN INJECTORS
DUAL CHAMBERED PEN INJECTORS
8.2.3.2. PEN INJECTORS, BY DESIGN
STANDARD PEN INJECTORS
CUSTOMIZED PEN INJECTORS
8.2.3.3. PEN INJECTORS, BY USABILITY
REUSABLE PEN INJECTORS
DISPOSABLE PEN INJECTORS
8.2.4. WEARABLE INJECTORS
9. NORTH AMERICA SELF-INJECTION MARKET, BY APPLICATION
9.1. OVERVIEW
9.2. NORTH AMERICA SELF-INJECTION MARKET, BY APPLICATION
9.3. HORMONAL DISORDERS
9.3.1. SELF-INJECTIONS FOR DIABETES
9.3.2. SELF-INJECTIONSFOR ANEMIA
9.3.3. REPRODUCTIVE HEALTH DISEASE
9.3.4. OSTEOPOROSIS
9.3.5. GROWTH HORMONE DISORDERS (GHD)
9.4. ONCOLOGY
9.5. AUTOIMMUNE DISEASES
9.5.1. RHEUMATOID ARTHRITIS
9.5.2. MULTIPLE SCLEROSIS
9.5.3. CROHN’S DISEASES
9.5.4. PSORIASIS
9.5.5. OTHER AUTOIMMUNE DISEASES
9.6. ORPHAN DISEASE
9.7. OTHER APPLICATIONS
9.7.1. PAIN MANAGEMENT
9.7.2. ALLERGY TREATMENT
9.7.3. AESTHETIC TREATMENTS
9.7.4. HEPATITIS C
9.7.5. HEMOPHILIA
10. NORTH AMERICA SELF-INJECTION MARKET, BY USAGE PATTERN
10.1. OVERVIEW
10.2. CURATIVE CARE
10.3. IMMUNIZATIONS
10.4. OTHER USAGE PATTERN
11. NORTH AMERICA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION
11.1. OVERVIEW
11.2. SKIN
11.3. CIRCULATORY/ MUSKOSKELETAL
11.4. ORGANS
11.5. CENTRAL NERVOUS SYSTEM
12. NORTH AMERICA SELF-INJECTION MARKET, BY END USER
12.1. OVERVIEW
12.2. HOSPITALS AND CLINICS
12.3. HOME HEALTHCARE SETTINGS
12.4. RESEARCH LABORATORIES
12.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
12.6. OTHER END USER
13. NORTH AMERICA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL
13.1. OVERVIEW
13.1.1. HOSPITAL PHARMACY
13.1.2. PHARMACY STORES
13.1.3. DIRECT TENDER
13.1.4. ONLINE PHARMACY
14. NORTH AMERICA SELF-INJECTION MARKET, BY GEOGRAPHY
14.1. OVERVIEW
14.2. NORTH AMERICA
14.2.1. U.S.
14.2.2. CANADA
14.2.3. MEXICO
15. NORTH AMERICA SELF INJECTION MARKET, COMPANY LANDSCAPE
15.1. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3. COMPANY SHARE ANALYSIS: EUROPE
15.4. COMPANY SHARE ANALYSIS: APAC
16. COMPANY PROFILES
16.1. ELCAM MEDICALCOMPANY OVERVIEW
16.1.1. ELCAM MEDICAL: COMPANY SNAPSHOT
16.1.2. PRODUCT PORTFOLIO
16.1.3. RECENT DEVELOPMENTS
16.2. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
16.2.1. COMPANY OVERVIEW
16.2.2. BESPAK: REVENUE ANALYSIS
16.2.3. PRODUCT PORTFOLIO
16.2.4. RECENT DEVELOPMENTS
16.3. SANOFI
16.3.1. COMPANY OVERVIEW
16.3.2. SANOFI: REVENUE ANALYSI
16.3.3. PRODUCT PORTFOLIO
16.3.4. RECENT DEVELOPMENTS
16.4. SANDOZ INTERNATIONAL GMBH
16.4.1. COMPANY OVERVIEW
16.5. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS
16.5.1. PRODUCT PORTFOLIO
16.5.2. RECENT DEVELOPMENTS
16.6. UNILIFE CORPORATION
16.6.1. COMPANY OVERVIEW
16.6.2. UNILIFE CORPORATION: REVENUEANALYSIS
16.6.3. PRODUCT PORTFOLIO
16.6.4. RECENT DEVELOPMENTS
16.7. WEST PHARMACEUTICAL SERVICES, INC
16.7.1. COMPANY OVERVIEW
16.7.2. WEST PHARMACEUTICAL SERVICES, INC: REVENUE ANALYSIS
16.7.3. PRODUCT PORTFOLIO
16.7.4. RECENT DEVELOPMENTS
16.8. PFIZER INC.
16.8.1. COMPANY OVERVIEW
16.8.2. PFIZER INC: REVENUE ANALYSIS
16.8.3. PRODUCT PORTFOLIO
16.8.4. RECENT DEVELOPMENTS
16.9. IMPAX LABORATORIES, INC.
16.9.1. COMPANY OVERVIEW
16.9.2. IMPAX LABORATORIES, INC: REVENUE ANALYSIS
16.9.3. PRODUCT PORTFOLIO
16.9.4. RECENT DEVELOPMENTS
16.10. PENJET CORPORATION
16.10.1. COMPANY OVERVIEW
16.10.2. PENJET CORPORATION: COMPANY SNAPSHOT
16.10.3. PRODUCT PORTFOLIO
16.10.4. RECENT DEVELOPMENTS
16.11. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS
16.11.1. COMPANY OVERVIEW
16.11.2. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS: COMPANY SNAPSHOT
16.11.3. PRODUCT PORTFOLIO
16.11.4. RECENT DEVELOPMENTS
16.12. WILHELM HASELMEIER GMBH & CO. KG
16.12.1. COMPANY OVERVIEW
16.12.2. HASELMEIER: COMPANY SNAPSHOT
16.12.3. PRODUCT PORTFOLIO
16.12.4. RECENT DEVELOPMENTS
16.13. ANTARES PHARMA
16.13.1. COMPANY OVERVIEW
16.13.2. ANTARES PHARMA: REVENUE ANALYSIS
16.13.3. PRODUCT PORTFOLIO
16.13.4. RECENT DEVELOPMENTS
16.14. BECTON, DICKINSON AND COMPANY
16.14.1. COMPANY OVERVIEW
16.14.2. BECTON, DICKINSON AND COMPANY: REVENUE ANALYSIS
16.14.3. PRODUCT PORTFOLIO
16.14.4. RECENT DEVELOPMENTS
16.15. GERRESHEIMER AG
16.15.1. COMPANY OVERVIEW
16.15.2. GERRESHEIMER AG: REVENUE ANALYSIS
16.15.3. PRODUCT PORTFOLIO
16.15.4. RECENT DEVELOPMENTS
16.16. MYLAN N.V
16.16.1. COMPANY OVERVIEW
16.16.2. MYLAN N.V.: REVENUE ANALYSIS
16.16.3. PRODUCT PORTFOLIO
16.16.4. RECENT DEVELOPMENTS
16.17. NOVO NORDISK
16.17.1. COMPANY OVERVIEW
16.17.2. NOVO NORDISK: REVENUE ANALYSIS
16.17.3. PRODUCT PORTFOLIO
16.17.4. RECENT DEVELOPMENTS
16.18. OWEN MUMFORD LTD
16.18.1. COMPANY OVERVIEW
16.18.2. OWEN MUMFORD LTD: COMPANY SNAPSHOT
16.18.3. PRODUCT PORTFOLIO
16.18.4. RECENT DEVELOPMENTS
16.19. PHARMAJET
16.19.1. COMPANY OVERVIEW
16.19.2. PHARMAJET: COMPANY SNAPSHOT
16.19.3. PRODUCT PORTFOLIO
16.19.4. RECENT DEVELOPMENTS
16.20. SHL GROUP
16.20.1. COMPANY OVERVIEW
16.20.2. SHL GROUP: COMPANY SNAPSHOT
16.20.3. PRODUCT PORTFOLIO
16.20.4. RECENT DEVELOPMENTS
16.21. YPSOMED
16.21.1. COMPANY OVERVIEW
16.21.2. YPSOMED: REVENUE ANALYSIS
16.21.3. PRODUCT PORTFOLIO
16.21.4. RECENT DEVELOPMENTS
17. RELATED REPORTS
LIST OF TABLES
TABLE 1 NORTH AMERICA SELF-INJECTION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 2 NORTH AMERICA SELF-INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 3 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT,2015 – 2024 (USD MILLION)
TABLE 4 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 5 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 6 NORTH AMERICA AUTO INJECTORSDEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 7 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 8 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 9 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 10 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 11 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 12 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 13 NORTH AMERICA SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 14 NORTH AMERICA AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 15 NORTH AMERICA HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 16 NORTH AMERICA OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 17 NORTH AMERICA SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 18 NORTH AMERICA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 19 NORTH AMERICA SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 20 NORTH AMERICA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 21 U.S. SELF-INJECTION MARKET, BY TYPE,2015 – 2024 (USD MILLION)
TABLE 22 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 23 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 24 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 25 U.S. AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 26 U.S. AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 27 U.S. AUTO INJECTORS DEVICE MARKET, BY DESIGN,2015 – 2024 (USD MILLION)
TABLE 28 U.S. AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 29 U.S. PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 30 U.S. PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 31 U.S. PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 32 U.S. SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 33 U.S. AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 34 U.S. HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 35 U.S. OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 36 U.S. SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 37 U.S. SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 38 U.S. SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 39 U.S. SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 40 CANADA SELF-INJECTION MARKET, BY TYPE,2015 – 2024 (USD MILLION)
TABLE 41 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 42 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 43 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 44 CANADA AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 45 CANADA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 46 CANADA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 47 CANADA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 48 CANADA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 49 CANADA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 50 CANADA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 51 CANADA SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 52 CANADA AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 53 CANADA HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 54 CANADA OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 55 CANADA SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 56 CANADA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 57 CANADA SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 58 CANADA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 59 MEXICO SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 60 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 61 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 62 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 63 MEXICO AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 64 MEXICO AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 65 MEXICO AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 66 MEXICO AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 67 MEXICO PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 68 MEXICO PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 69 MEXICO PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 70 MEXICO SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 71 MEXICO AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 72 MEXICO HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 73 MEXICO OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 74 MEXICO SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 75 MEXICO SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 76 MEXICO SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 77 MEXICO SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)TABLE LIST
TABLE 1 NORTH AMERICA SELF-INJECTION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 2 NORTH AMERICA SELF-INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 3 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT,2015 – 2024 (USD MILLION)
TABLE 4 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 5 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 6 NORTH AMERICA AUTO INJECTORSDEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 7 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 8 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 9 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 10 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 11 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 12 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 13 NORTH AMERICA SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 14 NORTH AMERICA AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 15 NORTH AMERICA HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 16 NORTH AMERICA OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 17 NORTH AMERICA SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 18 NORTH AMERICA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 19 NORTH AMERICA SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 20 NORTH AMERICA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 21 U.S. SELF-INJECTION MARKET, BY TYPE,2015 – 2024 (USD MILLION)
TABLE 22 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 23 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 24 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 25 U.S. AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 26 U.S. AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 27 U.S. AUTO INJECTORS DEVICE MARKET, BY DESIGN,2015 – 2024 (USD MILLION)
TABLE 28 U.S. AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 29 U.S. PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 30 U.S. PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 31 U.S. PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 32 U.S. SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 33 U.S. AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 34 U.S. HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 35 U.S. OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 36 U.S. SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 37 U.S. SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 38 U.S. SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 39 U.S. SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 40 CANADA SELF-INJECTION MARKET, BY TYPE,2015 – 2024 (USD MILLION)
TABLE 41 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 42 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 43 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 44 CANADA AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 45 CANADA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 46 CANADA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 47 CANADA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 48 CANADA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 49 CANADA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 50 CANADA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 51 CANADA SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 52 CANADA AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 53 CANADA HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 54 CANADA OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 55 CANADA SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 56 CANADA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 57 CANADA SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 58 CANADA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 59 MEXICO SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 60 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 61 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 62 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 63 MEXICO AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 64 MEXICO AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 65 MEXICO AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 66 MEXICO AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 67 MEXICO PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 68 MEXICO PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 69 MEXICO PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 70 MEXICO SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 71 MEXICO AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 72 MEXICO HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 73 MEXICO OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 74 MEXICO SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 75 MEXICO SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 76 MEXICO SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 77 MEXICO SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 1 NORTH AMERICA SELF-INJECTION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 2 NORTH AMERICA SELF-INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 3 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT,2015 – 2024 (USD MILLION)
TABLE 4 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 5 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 6 NORTH AMERICA AUTO INJECTORSDEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 7 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 8 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 9 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 10 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 11 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 12 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 13 NORTH AMERICA SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 14 NORTH AMERICA AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 15 NORTH AMERICA HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 16 NORTH AMERICA OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 17 NORTH AMERICA SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 18 NORTH AMERICA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 19 NORTH AMERICA SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 20 NORTH AMERICA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 21 U.S. SELF-INJECTION MARKET, BY TYPE,2015 – 2024 (USD MILLION)
TABLE 22 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 23 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 24 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 25 U.S. AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 26 U.S. AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 27 U.S. AUTO INJECTORS DEVICE MARKET, BY DESIGN,2015 – 2024 (USD MILLION)
TABLE 28 U.S. AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 29 U.S. PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 30 U.S. PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 31 U.S. PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 32 U.S. SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 33 U.S. AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 34 U.S. HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 35 U.S. OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 36 U.S. SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 37 U.S. SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 38 U.S. SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 39 U.S. SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 40 CANADA SELF-INJECTION MARKET, BY TYPE,2015 – 2024 (USD MILLION)
TABLE 41 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 42 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 43 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 44 CANADA AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 45 CANADA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 46 CANADA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 47 CANADA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 48 CANADA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 49 CANADA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 50 CANADA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 51 CANADA SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 52 CANADA AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 53 CANADA HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 54 CANADA OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 55 CANADA SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 56 CANADA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 57 CANADA SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 58 CANADA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 59 MEXICO SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 60 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 61 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 62 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 63 MEXICO AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 64 MEXICO AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 65 MEXICO AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 66 MEXICO AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 67 MEXICO PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 68 MEXICO PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 69 MEXICO PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 70 MEXICO SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 71 MEXICO AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 72 MEXICO HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 73 MEXICO OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 74 MEXICO SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 75 MEXICO SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 76 MEXICO SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 77 MEXICO SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)TABLE LIST
TABLE 1 NORTH AMERICA SELF-INJECTION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 2 NORTH AMERICA SELF-INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 3 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT,2015 – 2024 (USD MILLION)
TABLE 4 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 5 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 6 NORTH AMERICA AUTO INJECTORSDEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 7 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 8 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 9 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 10 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 11 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 12 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 13 NORTH AMERICA SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 14 NORTH AMERICA AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 15 NORTH AMERICA HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 16 NORTH AMERICA OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 17 NORTH AMERICA SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 18 NORTH AMERICA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 19 NORTH AMERICA SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 20 NORTH AMERICA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 21 U.S. SELF-INJECTION MARKET, BY TYPE,2015 – 2024 (USD MILLION)
TABLE 22 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 23 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 24 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 25 U.S. AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 26 U.S. AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 27 U.S. AUTO INJECTORS DEVICE MARKET, BY DESIGN,2015 – 2024 (USD MILLION)
TABLE 28 U.S. AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 29 U.S. PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 30 U.S. PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 31 U.S. PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 32 U.S. SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 33 U.S. AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 34 U.S. HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 35 U.S. OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 36 U.S. SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 37 U.S. SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 38 U.S. SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 39 U.S. SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 40 CANADA SELF-INJECTION MARKET, BY TYPE,2015 – 2024 (USD MILLION)
TABLE 41 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 42 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 43 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY,2015 – 2024 (USD MILLION)
TABLE 44 CANADA AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 45 CANADA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 46 CANADA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 47 CANADA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 48 CANADA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 49 CANADA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 50 CANADA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 51 CANADA SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 52 CANADA AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 53 CANADA HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 54 CANADA OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 55 CANADA SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 56 CANADA SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 57 CANADA SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 58 CANADA SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 59 MEXICO SELF-INJECTION MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 60 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 61 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY,2015 – 2024 (USD MILLION)
TABLE 62 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 63 MEXICO AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 64 MEXICO AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 65 MEXICO AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 66 MEXICO AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 67 MEXICO PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 68 MEXICO PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 69 MEXICO PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 70 MEXICO SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 71 MEXICO AUTOIMMUNE DISEASES SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 72 MEXICO HORMONAL DISORDERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 73 MEXICO OTHERS SELF-INJECTION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 74 MEXICO SELF-INJECTION MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 75 MEXICO SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 76 MEXICO SELF-INJECTION MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 77 MEXICO SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
LIST OF FIGURES
FIGURE 1 NORTH AMERICA DOMINATED THE NORTH AMERICA SELF-INJECTION MARKET IN 2016 WITH 46.6% SHARE, NEEDLE FREE INJECTOR IS THE DOMINATING PRODUCT TYPE AND HORMONAL DISORDER IS THE DOMINATING APPLICATION OF SELF-INJECTION MARKET
FIGURE 2 NORTH AMERICA IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR SELF-INJECTION MANUFACTURERS IN THE FORECAST PERIOD TO 2024
FIGURE 3 NORTH AMERICA SELF-INJECTION MARKET SNAPSHOT (2016)
FIGURE 4 NORTH AMERICA SELF-INJECTION MARKET: BY GEOGRAPHY (2016)
FIGURE 5 NORTH AMERICA SELF-INJECTION MARKET:BY COUNTRY (2017 & 2024)
FIGURE 6 NORTH AMERICA SELF-INJECTION MARKET BY COUNTRY (2016 & 2024)
FIGURE 7 NORTH AMERICA SELF-INJECTION MARKET, BY PRODUCT TYPE (2017 & 2024)
FIGURE 8 NORTH AMERICA SELF INJECTION MARKET: COMPANY SHARE 2016 (%)
FIGURE 1 NORTH AMERICA DOMINATED THE NORTH AMERICA SELF-INJECTION MARKET IN 2016 WITH 46.6% SHARE, NEEDLE FREE INJECTOR IS THE DOMINATING PRODUCT TYPE AND HORMONAL DISORDER IS THE DOMINATING APPLICATION OF SELF-INJECTION MARKET
FIGURE 2 NORTH AMERICA IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR SELF-INJECTION MANUFACTURERS IN THE FORECAST PERIOD TO 2024
FIGURE 3 NORTH AMERICA SELF-INJECTION MARKET SNAPSHOT (2016)
FIGURE 4 NORTH AMERICA SELF-INJECTION MARKET: BY GEOGRAPHY (2016)
FIGURE 5 NORTH AMERICA SELF-INJECTION MARKET:BY COUNTRY (2017 & 2024)
FIGURE 6 NORTH AMERICA SELF-INJECTION MARKET BY COUNTRY (2016 & 2024)
FIGURE 7 NORTH AMERICA SELF-INJECTION MARKET, BY PRODUCT TYPE (2017 & 2024)
FIGURE 8 NORTH AMERICA SELF INJECTION MARKET: COMPANY SHARE 2016 (%)
